Abstract
The possible role of PGs and NO in the development of S of DBA/2J mice was investigated by evaluating the effects of dexamethasone, indometacin, mifepristone plus dexamethasone on the S, as well as of L-NAME both on the S in the electrocorticogram of DBA/2J mice and on morphine- and deltorphin II-induced EEG seizure in rabbits. The results of our data indicate that: a) Both dexamethasone and indometacin (1,10,100 μg/kg/i.p.) reduced the S of DBA/2J mice and mifepristone, a glucocorticoid receptor antagonist (1,10,100 μg/kg/i.p.), totally blocked the steroid effect b) L-NAME (3 – 300 μg/mouse/ i.c.v.) dose-dependently reduced the S of DBA/2J mice whereas DNAME at the same doses did not affect S of mice. The inhibitory effect of L-NAME on S of mice was dose-dependently reversed by L-arginine (L-ARG, 3 – 300 μg/mouse/ i.c.v.) but not by D-arginine. Finally, GTN its own (3 – 300 μg/mouse/ i.c.v.) significantly increased the S of mice and it was also able to reverse the inhibition on S of mice operated by L-NAME. c) Morphine and deltorphin II (100 μg/icv/toto) produce EEG seizure activity in rabbits and L-NAME (300 μg/i.c.v./toto), injected 15 min before morphine or deltorphin II, dose dependently prevented the EEG ictal episodes, the spiking activity and the synchronized EEG pattern induced by morphine or deltorphin II. The inhibitory effect of L-NAME on morphine or deltorphin II seizures was dose-dependently reversed by L-arginine (300 μg/icv/toto) but not by D-arginine. Finally, GTN on its own (300 μg/icv/toto) significantly increased morphine or deltorphin II seizures in the rabbit and it was also able to reverse the inhibition on morphine or deltorphin II seizures operated by L-NAME. These results provide a strong evidence that both PGs and NO may play a significant role in the development of brain excitability.
Keywords: Prostaglandins, Nitric Oxide, Brain Excitability, dexamethasone, indometacin, electrocorticogram, glucocorticoid, receptor, antagonist, steroid
Current Medicinal Chemistry
Title: The Involvement of Prostaglandins and Nitric Oxide in the Development of Brain Excitability: A Relationship Study
Volume: 15 Issue: 24
Author(s): Anna Capasso
Affiliation:
Keywords: Prostaglandins, Nitric Oxide, Brain Excitability, dexamethasone, indometacin, electrocorticogram, glucocorticoid, receptor, antagonist, steroid
Abstract: The possible role of PGs and NO in the development of S of DBA/2J mice was investigated by evaluating the effects of dexamethasone, indometacin, mifepristone plus dexamethasone on the S, as well as of L-NAME both on the S in the electrocorticogram of DBA/2J mice and on morphine- and deltorphin II-induced EEG seizure in rabbits. The results of our data indicate that: a) Both dexamethasone and indometacin (1,10,100 μg/kg/i.p.) reduced the S of DBA/2J mice and mifepristone, a glucocorticoid receptor antagonist (1,10,100 μg/kg/i.p.), totally blocked the steroid effect b) L-NAME (3 – 300 μg/mouse/ i.c.v.) dose-dependently reduced the S of DBA/2J mice whereas DNAME at the same doses did not affect S of mice. The inhibitory effect of L-NAME on S of mice was dose-dependently reversed by L-arginine (L-ARG, 3 – 300 μg/mouse/ i.c.v.) but not by D-arginine. Finally, GTN its own (3 – 300 μg/mouse/ i.c.v.) significantly increased the S of mice and it was also able to reverse the inhibition on S of mice operated by L-NAME. c) Morphine and deltorphin II (100 μg/icv/toto) produce EEG seizure activity in rabbits and L-NAME (300 μg/i.c.v./toto), injected 15 min before morphine or deltorphin II, dose dependently prevented the EEG ictal episodes, the spiking activity and the synchronized EEG pattern induced by morphine or deltorphin II. The inhibitory effect of L-NAME on morphine or deltorphin II seizures was dose-dependently reversed by L-arginine (300 μg/icv/toto) but not by D-arginine. Finally, GTN on its own (300 μg/icv/toto) significantly increased morphine or deltorphin II seizures in the rabbit and it was also able to reverse the inhibition on morphine or deltorphin II seizures operated by L-NAME. These results provide a strong evidence that both PGs and NO may play a significant role in the development of brain excitability.
Export Options
About this article
Cite this article as:
Capasso Anna, The Involvement of Prostaglandins and Nitric Oxide in the Development of Brain Excitability: A Relationship Study, Current Medicinal Chemistry 2008; 15 (24) . https://dx.doi.org/10.2174/092986708785909076
DOI https://dx.doi.org/10.2174/092986708785909076 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Early Age of Migraine Onset is Independently Related to Cognitive Decline and Symptoms of Depression Affect Quality of Life
Current Neurovascular Research Selected PET Radioligands for Ion Channel Linked Neuroreceptor Imaging: Focus on GABA, NMDA and nACh Receptors
Current Topics in Medicinal Chemistry Neuronal High-Affinity Sodium-Dependent Glutamate Transporters (EAATs): Targets for the Development of Novel Therapeutics Against Neurodegenerative Diseases
Current Pharmaceutical Design Chvostek's Sign in Paediatric Practice
Current Pediatric Reviews Benzimidazole Derivatives as Centerally Acting Agents
Current Drug Therapy Acute Symptomatic Seizures in Geriatric Patients with Multiple Risk Factors - A Diagnostic Challenge
Current Aging Science Antimicrobial Drug Interactions in the Critically Ill Patients
Current Clinical Pharmacology Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors
Current Neuropharmacology Rivastigmine for Refractory REM Behavior Disorder in Mild Cognitive Impairment
Current Alzheimer Research AMPA Receptor Positive Allosteric Modulators: Potential for the Treatment of Neuropsychiatric and Neurological Disorders
Current Topics in Medicinal Chemistry The Mechanism of Action of Salsolinol in Brain: Implications in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism Antiepileptic Drug-Induced Hypersensitivity Syndrome Reactions
Current Drug Safety Voltage-Dependent Na+ Channels as Targets of BACE1 - Implications for Neuronal Firing and Beyond
Current Alzheimer Research Increased CRMP2 Phosphorylation is Observed in Alzheimers Disease; Does this Tell us Anything About Disease Development?
Current Alzheimer Research Emerging Synergisms Between Drugs and Physiologically-Patterned Weak Magnetic Fields: Implications for Neuropharmacology and the Human Population in the Twenty-First Century
Current Neuropharmacology Gut Microbiota as a Link between Modern Lifestyle and Alzheimer’s Disease
Current Aging Science Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis
Current Signal Transduction Therapy The Use of Microarrays to Study Childhood Developmental Brain Disorders
Current Genomics NLRP3 Inflammasome Activation Leads to Epileptic Neuronal Apoptosis
Current Neurovascular Research